Introduction Protelight Pharmaceuticals Australia PTY LTD is a subsidiary of Protelight Pharmaceuticals established in Australia. Protelight Pharmaceuticals is a high-tech biopharmaceutical enterprise mainly engaged in the research and production of innovative peptide drugs. The company has a high-level platform for de novo design of antimicrobial peptide drugs and innovative peptide formulation platforms. The pipeline layout of drug products under research is rich, including multiple first in class varieties of antimicrobial peptides and anti-tumor peptides, as well as innovative polypeptide preparations in different forms such as sprays, suppositories, inhalants, and injections. The company is committed to breaking through the global challenges of antibiotic resistance and cancer, striving to develop new peptide drugs to meet major clinical needs, enabling more patients to use good drugs, and alleviating the pain caused by diseases. |